Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$153.56 USD
+0.72 (0.47%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $153.57 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth F Momentum B VGM
Price, Consensus and EPS Surprise
DGX 153.56 +0.72(0.47%)
Will DGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DGX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DGX
AtriCure's (ATRC) AtriClip Receives Expanded CE-Mark Indication
Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY
DGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
INSPIRA (IINN) CART Gets FDA Listing, to Enhance Healthcare
Henry Schein (HSIC) Hurt by Macroeconomic Woes, Cyber Attacks
Chemed (CHE) Up 5.7% Since Last Earnings Report: Can It Continue?
Other News for DGX
FMI Funds Q2 2024 Shareholder Letter
Davis New York Venture Fund Fall Review 2024
Quest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business
Quest Diagnostics to acquire University Hospitals' outreach laboratory services business
Quest Diagnostics prices $1.85B senior notes